Evaluation of Risk Factors for Failed Seroconversion in the Management of Potential Lyssavirus Exposures - Scorecard - MDSpire

Evaluation of Risk Factors for Failed Seroconversion in the Management of Potential Lyssavirus Exposures

  • By

  • James Harris

  • Kate Alexander

  • Penny Hutchinson

  • Deborah Judd

  • Bonnie Macfarlane

  • Catherine Quagliotto

  • Vicki Slinko

  • James Smith

  • Nicolas Smoll

  • Mark Stickley

  • Alexandra Uren

  • Megan Young

  • January 15, 2026

  • 0 min

Share

Clinical Scorecard: Assessment of Factors Contributing to Incomplete Seroconversion in the Context of Potential Lyssavirus Exposures Management

At a Glance

CategoryDetail
ConditionLyssavirus exposure and rabies postexposure prophylaxis (PEP)
Key MechanismsRabies virus and Australian bat lyssavirus cause fatal encephalomyelitis; PEP involves rabies vaccine and immunoglobulin to induce protective immunity and prevent CNS infection
Target PopulationIndividuals with potential lyssavirus exposures, including bat bites/scratches and travelers exposed to terrestrial rabies-endemic mammals
Care SettingPublic health units managing potential lyssavirus exposures and coordinating PEP

Key Highlights

  • Incorrect rabies vaccine administration site or vaccine given in the same arm within 72 hours of rabies immunoglobulin significantly increases risk of failed seroconversion.
  • Older age (≥65 years) independently increases risk of nontherapeutic serology after rabies PEP.
  • Failure of rabies PEP is rare but may be mitigated by immediate repeat vaccination if administration errors occur, without waiting for serology.

Guideline-Based Recommendations

Diagnosis

  • Use serology testing to confirm therapeutic immune response when risk of PEP failure is suspected.
  • Rabies serology assessed by ELISA in Australian laboratories.

Management

  • Administer rabies vaccine in the deltoid muscle (or thigh in infants) to avoid subcutaneous injection.
  • Administer rabies immunoglobulin (RIG) infiltrated into the wound and any leftover into a large muscle, avoiding the same arm as vaccine within 72 hours.
  • Repeat rabies vaccine dose immediately if given in wrong site or same arm as RIG within 72 hours, without waiting for serology.

Monitoring & Follow-up

  • Recommend serology testing when improper vaccine or RIG administration is suspected or in older patients.
  • Monitor serology outcomes to identify failed seroconversion.

Risks

  • Incorrect vaccine site administration (RR 10.8) and vaccine given in same arm within 72 hours of RIG (RR 5.6) increase risk of failed seroconversion.
  • Age ≥65 years increases risk of nontherapeutic serology (RR 4.0).
  • Improper wound care, poor vaccine quality, or storage issues may also contribute to PEP failure.

Patient & Prescribing Data

Potential lyssavirus exposure cases receiving rabies PEP in Southeast Queensland, including older adults and travelers.

Proper vaccine and RIG administration critical to ensure therapeutic immune response; older adults may require closer monitoring or alternative strategies.

Clinical Best Practices

  • Ensure rabies vaccine is administered intramuscularly in the correct site (deltoid or thigh).
  • Avoid administering rabies vaccine in the same arm within 72 hours of RIG administration.
  • If administration errors occur, immediately repeat the vaccine dose without waiting for serology confirmation.
  • Consider age-related immune response variability when managing PEP and interpreting serology.
  • Coordinate management through public health units for timely PEP and follow-up.

References

Original Source(s)

Related Content